Compare · ACCD vs LOAC
ACCD vs LOAC
Side-by-side comparison of Accolade Inc. (ACCD) and Longevity Acquisition Corporation (LOAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while LOAC operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for LOAC).
- Company
- Accolade Inc.
- Longevity Acquisition Corporation
- Price
- $7.03+0.00%
- -
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2018
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest LOAC
- SEC Form EFFECT filed by Longevity Acquisition Corporation
- SEC Form 15-15D filed by Longevity Acquisition Corporation
- SEC Form POS AM filed by Longevity Acquisition Corporation
- SEC Form 25-NSE filed by Longevity Acquisition Corporation
- 4D pharma Announces Completion of Merger With Longevity Acquisition Corporation
- SEC Form 425 filed by Longevity Acquisition Corporation
- SEC Form 8-K filed by Longevity Acquisition Corporation
- SEC Form 425 filed by Longevity Acquisition Corporation
- Longevity Acquisition Corporation Announces Results of Special Meeting of Shareholders
- SEC Form 425 filed by Longevity Acquisition Corporation